Материалы доступны только для специалистов сферы здравоохранения. Авторизуйтесь или зарегистрируйтесь.
Подход к выбору противоастматической терапии
Подход к выбору противоастматической терапии
Материалы доступны только для специалистов сферы здравоохранения. Авторизуйтесь или зарегистрируйтесь.
Полный текст
Список литературы
1. Asthma. Quick asthma facts and The Faces of asthma. Geneva: World Health Organization, 2010. Available from: http://www.who.int/respiratory/asthma/en/
2. Bateman ED, Bousquet J, Braunstein GL. Is overall asthma controlbeing achieved ? A hypotesis-generating study. Eur Respir J 2001; 17: 589–95.
3. Белевский А.С. Взгляд на пациента с точки зрения пациента: исследование INSPIRE. Cons. Med. Т. 9. 3 (207). http://old.consilium-medicum.com/media/consilium/ 07_03/40.shtml
4. Черняк Б.А., Воржева И.И. Агонисты β2-адренергических рецепторов в терапии бронхиальной астмы: вопросы эффективности и безопасности. Сons. Med. 2006; 8 (10).
5. National Institutes of Health, National Heart, Lung and Blood Institute. Global Initiative for asthma: pocket Guide for Asthma Management and Prevention. NHLBI/WHO NIH; 1998. Publication No96-36558B.
6. Sears MR, Taylor DR, Print CG et al. Regular inhaled beta-agonist treatment in bronchial asthma. Lancet 1990; 336: 1391–6.
7. Spitzer WO, Suissa S, Ernst P et al. The use of β-agonists and the risk of death and near death from asthma. N Engl J Med 1992; 326: 501–6.
8. Drazen JM, Israel E, Boushey HA et al. Comparison of regularly scheduled with as-needed use of albuterol in mild asthma. N Engl J Med 1996; 335: 841–7.
9. Pearlman DS, Chervinsky P, LaForce C et al. A comparison of salmeterol with albuterol in the treatment of mild-to-moderate asthma. N Engl J Med 1992; 327: 1420–5.
10. Kesten S, Chapman KR, Broder I et al. A three-month comparison of twice daily inhaled formoterol versus four times daily inhaled albuterol in the management of stable asthma. Am Rev Respir Dis 1991; 144: 622–5.
11. Greening AP, Ind PW, Northfield M, Shaw G. Added salmeterol versus higher-dose corticosteroid in asthma patients with symptoms on existing inhaled corticosteroid. Lancet 1994; 344: 219–24.
12. Van Essen-Zandvliet EE, Hughes MD, Waalkens HJ et al. Effects of 22 months of treatment with inhaled cor-ticosteroids and/or beta-2-agonists on lung function, airway responsive-ness, and symptoms in children with asthma. Am Rev Respir Dis 1992; 146: 547–54.
13. Global Initiative for Asthma. Global strategy for asthma management and prevention. Washington, D.C.: National Heart, Lung, and Blood Institute, 1995. Publication №95-3659.
14. Nora YK Chew, Hak-Kim Chan. In vitro aerosol performance and dose uniformity between the Foradile aerolizer and the Oxis Turbuhaler. J Aerosol Med 2001; 14 (4): 495–501.
2. Bateman ED, Bousquet J, Braunstein GL. Is overall asthma controlbeing achieved ? A hypotesis-generating study. Eur Respir J 2001; 17: 589–95.
3. Белевский А.С. Взгляд на пациента с точки зрения пациента: исследование INSPIRE. Cons. Med. Т. 9. 3 (207). http://old.consilium-medicum.com/media/consilium/ 07_03/40.shtml
4. Черняк Б.А., Воржева И.И. Агонисты β2-адренергических рецепторов в терапии бронхиальной астмы: вопросы эффективности и безопасности. Сons. Med. 2006; 8 (10).
5. National Institutes of Health, National Heart, Lung and Blood Institute. Global Initiative for asthma: pocket Guide for Asthma Management and Prevention. NHLBI/WHO NIH; 1998. Publication No96-36558B.
6. Sears MR, Taylor DR, Print CG et al. Regular inhaled beta-agonist treatment in bronchial asthma. Lancet 1990; 336: 1391–6.
7. Spitzer WO, Suissa S, Ernst P et al. The use of β-agonists and the risk of death and near death from asthma. N Engl J Med 1992; 326: 501–6.
8. Drazen JM, Israel E, Boushey HA et al. Comparison of regularly scheduled with as-needed use of albuterol in mild asthma. N Engl J Med 1996; 335: 841–7.
9. Pearlman DS, Chervinsky P, LaForce C et al. A comparison of salmeterol with albuterol in the treatment of mild-to-moderate asthma. N Engl J Med 1992; 327: 1420–5.
10. Kesten S, Chapman KR, Broder I et al. A three-month comparison of twice daily inhaled formoterol versus four times daily inhaled albuterol in the management of stable asthma. Am Rev Respir Dis 1991; 144: 622–5.
11. Greening AP, Ind PW, Northfield M, Shaw G. Added salmeterol versus higher-dose corticosteroid in asthma patients with symptoms on existing inhaled corticosteroid. Lancet 1994; 344: 219–24.
12. Van Essen-Zandvliet EE, Hughes MD, Waalkens HJ et al. Effects of 22 months of treatment with inhaled cor-ticosteroids and/or beta-2-agonists on lung function, airway responsive-ness, and symptoms in children with asthma. Am Rev Respir Dis 1992; 146: 547–54.
13. Global Initiative for Asthma. Global strategy for asthma management and prevention. Washington, D.C.: National Heart, Lung, and Blood Institute, 1995. Publication №95-3659.
14. Nora YK Chew, Hak-Kim Chan. In vitro aerosol performance and dose uniformity between the Foradile aerolizer and the Oxis Turbuhaler. J Aerosol Med 2001; 14 (4): 495–501.
Авторы
Е.В.Назарова, Е.А.Латышева, К.С.Павлова, О.М.Курбачева, Н.И.Ильина
ФГБУ ГНЦ Институт иммунологии ФМБА России, Москва
ФГБУ ГНЦ Институт иммунологии ФМБА России, Москва
Цель портала OmniDoctor – предоставление профессиональной информации врачам, провизорам и фармацевтам.